Hydrogen sulfide mitigates matrix metalloproteinase-9 activity and neurovascular permeability in hyperhomocysteinemic mice

Neurochemistry International

Volumn 56, Issue 2, 2010, Pages 301-307

  Tyagi, Neetu ^a   Givvimani, Srikanth ^a   Qipshidze, Natia ^a   Kundu, Soumi ^a   Kapoor, Shray ^a   Vacek, Jonathan C ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Blood brain barrier; Cystathionine synthase (CBS); Cystathionine lyase (CSE); Tissue inhibitors of matrix metalloproteinases

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; DRINKING WATER; GELATINASE A; GELATINASE B; HOMOCYSTEINE; HYDROGEN SULFIDE; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN TISSUE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HETEROZYGOSITY; HYPERHOMOCYSTEINEMIA; MEMBRANE PERMEABILITY; MICROSCOPY; MICROVASCULATURE; MOUSE; NEUROPROTECTION; NONHUMAN; PIA MATER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; CAPILLARY PERMEABILITY; HYDROGEN SULFIDE; HYPERHOMOCYSTEINEMIA; MATRIX METALLOPROTEINASE 9; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 77149155639     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.11.002     Document Type: Article

References (45)

1. Abe K., Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 1996, 16:1066-1071.
2. Ahonen M., Poukkula M., Baker A.H., Kashiwagi M., Nagase H., Eriksson J.E., Kahari V.M. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003, 22:2121-2134.
3. Baker A.H., Zaltsman A.B., George S.J., Newby A.C. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 1998, 101(6):1478-1487.
4. Blackstone E., Morrison M., Roth M.B. H2S induces a suspended animation-like state in mice. Science 2005, 308:518.
5. Dollery C.M., McEwan J.R., Wang M., Sang Q.A., Liu Y.E., Shi Y.E. TIMP-4 is regulated by vascular injury in rats. Ann. N.Y. Acad. Sci. 1999, 878:740-741.
6. Elrod J.W., Calvert J.W., Morrison J., Doeller J.E., Kraus D.W., Tao L., Jiao X., Scalia R., Kiss L., Szabo C., Kimura H., Chow C.W., Lefer D.J. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15560-15565.
7. Goodwin L.R., Francom D., Dieken F.P., Taylor J.D., Warenycia N.W., Reiffenstein R.J., Dowling G. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: post-mortem studies and two case reports. J. Anal. Toxicol. 1989, 13:105-109.
8. Hosoki R., Matsuki N., Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 1997, 237:527-531.
9. Ishii I., Akahoshi N., Yu X.N., Kobayashi Y., Namekata K., Komaki G., Kimura H. Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem. J. 2004, 381:113-123.
10. Kubo S., Doe I., Kurokawa Y., Nishikawa H., Kawabata A. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 2007, 232:138-146.
11. Kumar M., Tyagi N., Moshal K.S., Sen U., Kundu S., Mishra P.K., Givvimani S., Tyagi S.C. Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery. Neurochem. Int. 2008, 53:214-219.
12. Li X., Jin H., Bin G., Wang L., Tang C., Du J. Endogenous hydrogen sulfide regulates pulmonary artery collagen remodeling in rats with high pulmonary blood flow. Exp. Biol. Med. (Maywood) 2009, 234:504-512.
13. Lominadze D., Roberts A.M., Tyagi N., Moshal K.S., Tyagi S.C. Homocysteine causes cerebrovascular leakage in mice. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1206-H1213.
14. Miles E.W., Kraus J.P. Cystathionine beta-synthase: structure, function, regulation, and location of homocystinuria-causing mutations. J. Biol. Chem. 2004, 279:29871-29874.
15. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 2006, 69:562-573.
16. Qu K., Lee S.W., Bian J.S., Low C.M., Wong P.T. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem. Int. 2008, 52(January (1-2)):155-165.
17. Rabaneda L.G., Carrasco M., Lopez-Toledano M.A., Murillo-Carretero M., Ruiz F.A., Estrada C., Castro C. Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression. FASEB J. 2008, 22:3823-3835.
18. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med. 1998, 49:31-62.
19. Richardson C.J., Magee E.A., Cummings J.H. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin. Chim. Acta 2000, 293:115-125.
20. Robert K., Pages C., Ledru A., Delabar J., Caboche J., Janel N. Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 2005, 133:925-935.
21. Sachdev P.S., Valenzuela M., Wang X.L., Looi J.C., Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 2002, 58:1539-1541.
22. Santiard-Baron D., Aupetit J., Janel N. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease. Neurosci. Res. 2005, 53:447-449.
23. Schicho R., Krueger D., Zeller F., Von Weyhern C.W., Frieling T., Kimura H., Ishii I., De G.R., Campi B., Schemann M. Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea-pig and human colon. Gastroenterology 2006, 131:1542-1552.
24. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 1999, 19:217-246.
25. Sen U., Tyagi N., Kumar M., Moshal K.S., Rodriguez W.E., Tyagi S.C. Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells. Am. J. Physiol. Cell Physiol. 2007, 293:C1779-C1787.
26. Sen U., Basu P., Abe O.A., Givvimani S., Tyagi N., Metreveli N., Shah K.S., Passmore J.C., Tyagi S.C. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am. J. Physiol. Renal Physiol. 2009, 297:F410-F419.
27. Shapiro S.S., Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika 1965, 52(December (3/4)):591-611.
28. Sood H.S., Cox M.J., Tyagi S.C. Generation of nitrotyrosine precedes activation of metalloproteinase in myocardium of hyperhomocysteinemic rats. Antioxid. Redox. Signal. 2002, 4:799-804.
29. Sun Y.G., Cao Y.X., Wang W.W., Ma S.F., Yao T., Zhu Y.C. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc. Res. 2008, 79:632-641.
30. Tang G., Wu L., Liang W., Wang R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol. Pharmacol. 2005, 68:1757-1764.
31. Teague B., Asiedu S., Moore P.K. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br. J. Pharmacol. 2002, 137:139-145.
32. Truong D.H., Eghbal M.A., Hindmarsh W., Roth S.H., O'Brien P.J. Molecular mechanisms of hydrogen sulfide toxicity. Drug Metab. Rev. 2006, 38:733-744.
33. Tyagi N., Lominadze D., Gillespie W., Moshal K.S., Sen U., Rosenberger D.S., Steed M., Tyagi S.C. Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of homocysteine. Clin. Chem. Lab. Med. 2007, 45:1777-1784.
34. 2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid. Redox. Signal. 2009, 11:25-33.
35. Tyagi N., Moshal K.S., Tyagi S.C., Lominadze D. γ-Aminbuturic acid A receptor mitigates homocysteine-induced endothelial cell permeability. Endothelium 2007, 14:315-323.
36. Tummalapalli C.M., Heath B.J., Tyagi S.C. Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts. J. Cell Biochem. 2001, 80(4):512-521.
37. Wagner C.A. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator. J. Nephrol. 2009, 22(March-April (2)):173-176.
38. Wald D.S., Law M., Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002, 325:1202.
39. 2S be the third endogenous gaseous transmitter?. FASEB J. 2002, 16:1792-1798.
40. Whiteman M, Cheung N.S., Zhu Y.Z., Chu S.H., Siau J.L., Wong B.S., Armstrong J.S., Moore P.K. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?. Biochem. Biophys. Res. Commun. 2005, 326:794-798.
41. Yan S.K., Chang T., Wang H., Wu L., Wang R., Meng Q.H. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2006, 15(2):485-491.
42. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322(October (5901)):587-590.
43. 2S in rat insulin-secreting cells and the underlying mechanisms. J. Physiol. 2005, 569:519-531.
44. Zagli G., Patacchini R., Trevisani M., Abbate R., Cinotti S., Gensini G.F., Masotti G., Geppetti P. Hydrogen sulfide inhibits human platelet aggregation. Eur. J. Pharmacol. 2007, 559:65-68.
45. Zhao W., Zhang J., Lu Y., Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 2001, 20:6008-6016.